AgingNEUROAGENCT01481246
Neurocognitive Study for the Aging-a Longitudinal Study With a Greek Cypriot Cohort
An observational study of Aging and Memory Impairment, run by University of Cyprus at 1 site in Cyprus.
Trial summary
The Neurocognitive Study for the Aging (NEUROAGE) was initially funded by the Cyprus Innovation Foundation and has received subsequent funding by the European Union Regional Development Fund. Read more about this study
- Who is it for?
- Ages 60 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Aging, Memory Impairment, Cognitive Decline
- What is being tested?
- Categorization training and Psychosocial and Psychoeducational Group training
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 1,000 participants
- Where
- 1 siteCyprus
- Study dates
- Jul 2009to Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Normal older adults and adults with cognitive decline are recruited in this study
Who may be able to join
- healthy with no prior neurological history
Who cannot join
- prior neurological history or significant psychiatric history
Trial locations and contacts
1 site in 1 country.
Cyprus1 site, 1 recruiting
- Recruiting
University of Cyprus
Nicosia, 1678
Fofi Constantinidou, Ph.D., 35722894437, fofic@ucy.ac.cy
Fofi Constantinidou, Ph.D.
About this study
Official title: The Neurocognitive Study for the Aging
The Neurocognitive Study for the Aging (NEUROAGE) was initially funded by the Cyprus Innovation Foundation and has received subsequent funding by the European Union Regional Development Fund. The project focuses on the understanding of the effects of age on neurocognitive abilities such as attention, memory, language, categorization, and executive functioning. In addition, specific arms of the project investigate the effects of a theory-driven hierarchical training program, the Categorization Program, to improve cognitive abilities in adults with Mild Cognitive Impairment (MCI) and of a group intervention program focusing on cognitive and psychosocial abilities. Over 1000 adults ages 40 and older have been recruited in the NEUROAGE project thus far. The grant was awarded to the University of Cyprus, with Professor Fofi Constantinidou as the PI.
Read the detailed description
Given the fact that older adults are expected to live longer while maintaining their social and professional activities, the development of effective cognitive retraining methodologies designed to maximize independence has been of interest. In addition to changes caused by the normal aging process, older adults over 65 are at a high risk for developing dementia. About 8-12% of the older adult population will demonstrate a pre-dementia syndrome referred to as Mild Cognitive Impairment (MCI) which is considered a prodrome to dementia. Consequently, it is important to identify variables that contribute to the development of MCI as well as neurocognitive therapy approaches to help patients improve their level of functioning.
Categorization is one of the most fundamental cognitive processes. The ability to divide the world into discrete categories is a rudimentary process beginning early in life and continues to be developed and refined across the lifespan. This underlying process is crucial to a variety of neurocognitive abilities including attention and memory and can influence vocational and educational reintegration. Normal aging results in categorization deficits which in turn can interfere with the individual's ability to attend, remember, and organize information. This difficulty could hamper activities of daily living, social participation, and independence. This project implements an innovative treatment program based on current theoretical models of human cognition designed to improve neurocognitive abilities.
One of the objectives of the project is to provide evidence on the effectiveness of a systematic and hierarchical neurocognitive therapy method, the Categorization Program (CP) in adults with MCI and in normal older adults. It is hypothesized that the CP will be an effective treatment approach to improve categorization abilities in both groups of subjects. In addition, since 2020, we have been implementing a group intervention program as part of our recent funding to investigate its feasibility in healthy older adults and in adults with MCI.
The following activities have been taking place:
- Initially, a population-based sample of 500 older adults was tested using a battery of neuropsychological measures. Normal older adults are reassessed every two years. Currently, more than 800 healthy adults have been recruited in this project.
- Second, normal OA and adults with MCI have been randomly assigned into either the treated or untreated groups. The treated groups receive the CP training in order to test its effectiveness.
- Third, the long term effects of cognitive retraining is being assessed.
- Finally, the project examines the relationship between the categorization tasks, neuropsychological performance, functional outcome measures, and subject characteristics including health indices, education, and biomarkers. Theoretical constructs such as Cognitive Reserve have been explored as part of this project.
The long-term objective of this research program is to determine variables that influence cognitive decline in older adults and develop effective neurocognitive therapy techniques.
- Conditions
- Aging, Memory Impairment, Cognitive Decline, Mild Cognitive Disorder
- Being tested
- Categorization training, Psychosocial and Psychoeducational Group training
- Keywords
- neurorehabilitation, cognition, aging, MCI, cognitive decline
- Medical subject headings
- Memory Disorders, Cognitive Dysfunction, Neurocognitive Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Categorization trainingBehavioural
Behavioral intervention consisting of cognitive training exercises to improve categorization performance
Psychosocial and Psychoeducational Group trainingBehavioural
Group treatment with a focus on psychosocial and psychoeducational intervention in healthy adults and in adults with cognitive decline. Ten week cycle, 2 hours per week group intervention study.
| Study group | Role | What they receive |
|---|---|---|
| Normal Aging/Cognitive Decline | Health adults as well as adults with MCI and early stage AD are being recruited in the study Receives: Behavioral: Categorization training; Behavioral: Psychosocial and Psychoeducational Group training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neuropsychological Tests
a variety of cognitive tests as well as psychosocial measures are used in this project
Measured: on going
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Nov 2011 (estimated)
- Study startJul 2009
- Primary completionDec 2025 (estimated)
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Cyprus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Fofi Constantinidou, University of Cyprus
- Investigators
- Fofi Constantinidou, Ph.D., Principal investigator, University of Cyprus
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01481246
- Sponsor's protocol ID
- Humanities/Society/0308(ΒΕ)/07
- Other IDs
- Humanities/Society/0308(ΒΕ)/07, SKEPSH, EXCELLENCE/1216/0404
- Acronym
- NEUROAGE
- Status last verified
- Aug 2023
- First submitted
- 25 Nov 2011
- Last updated
- 22 Aug 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Chadjikyprianou A, Constantinidou F. Effectiveness of a Novel Multidimensional Group Intervention to Enhance Subjective Cognitive and Psychosocial Functioning in Healthy Older Adults. J Aging Health. 2025 Oct 24:8982643251391224. doi: 10.1177/08982643251391224. Online ahead of print.
PubMed 41135181Chadjikyprianou A, Constantinidou F. A new multidimensional group intervention for cognitive and psychosocial functioning for older adults: Background, content, and process evaluation. Front Med (Lausanne). 2023 Apr 20;10:1161060. doi: 10.3389/fmed.2023.1161060. eCollection 2023.
PubMed 37153102
Study at a glance
From the registry record, last updated by the sponsor on 22 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Neurocognitive Study for the Aging
- ClinicalTrials.gov ID
- NCT01481246
- Acronym / sponsor ID
- NEUROAGE / Humanities/Society/0308(ΒΕ)/07
- Conditions
- Aging, Memory Impairment, Cognitive Decline, Mild Cognitive Disorder
- Keywords
- neurorehabilitation, cognition, aging, MCI, cognitive decline
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- University of CyprusUniversity, hospital or other
- Study start
- Jul 2009
- Primary completion
- Dec 2025 (estimated)
- Study completion
- Dec 2025 (estimated)
- First posted
- 29 Nov 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Neurocognitive Study for the Aging (NEUROAGE) was initially funded by the Cyprus Innovation Foundation and has received subsequent funding by the European Union Regional Development Fund. The project focuses on the understanding of the effects of age on neurocognitive abilities such as attention, memory, language, categorization, and executive functioning. In addition, specific arms of the project investigate the effects of a theory-driven hierarchical training program, the Categorization Program, to improve cognitive abilities in adults with Mild Cognitive Impairment (MCI) and of a group intervention program focusing on cognitive and psychosocial abilities. Over 1000 adults ages 40 and older have been recruited in the NEUROAGE project thus far. The grant was awarded to the University of Cyprus, with Professor Fofi Constantinidou as the PI.
Detailed description
Given the fact that older adults are expected to live longer while maintaining their social and professional activities, the development of effective cognitive retraining methodologies designed to maximize independence has been of interest. In addition to changes caused by the normal aging process, older adults over 65 are at a high risk for developing dementia. About 8-12% of the older adult population will demonstrate a pre-dementia syndrome referred to as Mild Cognitive Impairment (MCI) which is considered a prodrome to dementia. Consequently, it is important to identify variables that contribute to the development of MCI as well as neurocognitive therapy approaches to help patients improve their level of functioning.
Categorization is one of the most fundamental cognitive processes. The ability to divide the world into discrete categories is a rudimentary process beginning early in life and continues to be developed and refined across the lifespan. This underlying process is crucial to a variety of neurocognitive abilities including attention and memory and can influence vocational and educational reintegration. Normal aging results in categorization deficits which in turn can interfere with the individual's ability to attend, remember, and organize information. This difficulty could hamper activities of daily living, social participation, and independence. This project implements an innovative treatment program based on current theoretical models of human cognition designed to improve neurocognitive abilities.
One of the objectives of the project is to provide evidence on the effectiveness of a systematic and hierarchical neurocognitive therapy method, the Categorization Program (CP) in adults with MCI and in normal older adults. It is hypothesized that the CP will be an effective treatment approach to improve categorization abilities in both groups of subjects. In addition, since 2020, we have been implementing a group intervention program as part of our recent funding to investigate its feasibility in healthy older adults and in adults with MCI.
The following activities have been taking place:
- Initially, a population-based sample of 500 older adults was tested using a battery of neuropsychological measures. Normal older adults are reassessed every two years. Currently, more than 800 healthy adults have been recruited in this project.
- Second, normal OA and adults with MCI have been randomly assigned into either the treated or untreated groups. The treated groups receive the CP training in order to test its effectiveness.
- Third, the long term effects of cognitive retraining is being assessed.
- Finally, the project examines the relationship between the categorization tasks, neuropsychological performance, functional outcome measures, and subject characteristics including health indices, education, and biomarkers. Theoretical constructs such as Cognitive Reserve have been explored as part of this project.
The long-term objective of this research program is to determine variables that influence cognitive decline in older adults and develop effective neurocognitive therapy techniques.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Normal Aging/Cognitive Decline | – | Behavioral: Categorization training, Behavioral: Psychosocial and Psychoeducational Group trainingHealth adults as well as adults with MCI and early stage AD are being recruited in the study |
Who may qualify
- Ages
- 60 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Normal older adults and adults with cognitive decline are recruited in this study
Key inclusion criteria (1 listed)
- healthy with no prior neurological history
Key exclusion criteria (1 listed)
- prior neurological history or significant psychiatric history
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Categorization trainingBehavioral intervention consisting of cognitive training exercises to improve categorization performance | Behavioural | Normal Aging/Cognitive Decline |
| Psychosocial and Psychoeducational Group trainingGroup treatment with a focus on psychosocial and psychoeducational intervention in healthy adults and in adults with cognitive decline. Ten week cycle, 2 hours per week group intervention study. | Behavioural | Normal Aging/Cognitive Decline |
Primary outcome
Neuropsychological Tests
Time frame: on going
a variety of cognitive tests as well as psychosocial measures are used in this project
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Aug 2023.
- Derived from this study: PubMed 41135181Chadjikyprianou A, Constantinidou F. Effectiveness of a Novel Multidimensional Group Intervention to Enhance Subjective Cognitive and Psychosocial Functioning in Healthy Older Adults. J Aging Health. 2025 Oct 24:8982643251391224. doi: 10.1177/08982643251391224. Online ahead of print.
- Derived from this study: PubMed 37153102Chadjikyprianou A, Constantinidou F. A new multidimensional group intervention for cognitive and psychosocial functioning for older adults: Background, content, and process evaluation. Front Med (Lausanne). 2023 Apr 20;10:1161060. doi: 10.3389/fmed.2023.1161060. eCollection 2023.
- Center for Applied NeuroscienceLink provided by the sponsor.
Related trials for Aging
RecruitingObservational study
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Aging
Not yet recruitingPhase 2
Effects of Switch to Doravirine/Islatravir vs. Continued Antiretroviral Therapy on Biomarkers of Aging Among Virologically Suppressed People With HIV
Epigenetic Aging
Not yet recruitingObservational study
China Healthy Aging and Fitness Longitudinal Study
Physical Fitness, Aging
Not yet recruiting
Effects of Different Amounts of Plyometric Exercise Without Jumping in Physically Inactive Older Adults
Sedentary Behavior / Physical Inactivity, Aging
RecruitingObservational study
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
Gait Disorders, Neurologic, Atypical Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fofi Constantinidou, Ph.D. principal investigator
University of Cyprus
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Aging and Memory Impairment, run by University of Cyprus at 1 site in Cyprus.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Fofi Constantinidou, Ph.D. (35722892078, fofic@ucy.ac.cy), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neuropsychological Tests (time frame: on going). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01481246, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2023; AzTrials last refreshed its copy on 27 Oct 2026.